Company / R&D per Share
Mind Medicine (MindMed) Inc. R&D per Share History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D per Share
$1.32
FY2025
5-year range
$0.93 / $1.33
FY2021-FY2025
Trend
+42.1%
vs FY2024
Sector context
#133 of 208
Health Care
What the data says
At $1.32, Mind Medicine (MindMed) Inc.'s r&d per share ranks #133 of 208 in the Health Care sector. R&D per Share has fluctuated over the past 7 years, ranging from $0.07 in FY2020 to $1.33 in FY2023.
Based on SEC 10-K filings.
1.32 in FY2025 with a 5-year CAGR of +79.9%.
Remained stable around $1.32 over the past 2 years.
Health Care sector context is included.
R&D per Share over time
Growth rates
- 3-Year CAGR
- +4.0%
- 5-Year CAGR
- +79.9%
- 10-Year CAGR
- -
Sector benchmark
#133 of 208 in Health CareTop 64% of 208This company $1.32 Sector average $28.82
▼
-95.4% below sector average
Key checks
Key Insights
- In FY2025, r&d per share increased 42.1% year-over-year.
- Ranks #133 out of 208 companies in the Health Care sector.
- Peak r&d per share was recorded in FY2023.
- Lowest r&d per share in the period was in FY2020.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 0.70 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.32 | +42.1% |
| FY2024 | $0.93 | -30.4% |
| FY2023 | $1.33 | +13.6% |
| FY2022 | $1.17 | -7.8% |
| FY2021 | $1.27 | +1715.8% |
| FY2020 | $0.07 | -4.7% |
| FY2019 | $0.07 | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026